Businesses may claim tariff refunds for unlawful policies. See how a $1B class action could impact future trade and what steps to take now.
Editorial Team
·
2026 biotech IPOs: What do investors demand? Strong clinical data and clear commercialization paths are key for companies like GenePath.
·
Iran's internal protests could fuel Middle East instability by 2026. Understand how economic woes and leadership shifts impact regional power dynamics.
·
Why do 40% of biotech startups fail post-seed funding? Understand the R&D valley of death, VC trends, and new funding strategies.
·
How will the EU AI Act protect young users by 2026? Learn about new rules for ethical AI, privacy, and education for youth's digital future.
·
·
8 min read
US Treasury's 2026 IEEPA rules demand corporate transparency for tariff refunds. See how this trade policy shift impacts businesses and compliance.
·
·
5 min read
See how OmniLogistics used AI to cut inefficiencies by 15% and boost profits. Learn how human-AI collaboration works for real companies.
·
·
8 min read
2026's new tariff litigation changes global trade. Understand how WTO and US Court of International Trade rulings impact your business.
·
·
8 min read
Brussels summit initiates global AI child safety rules. Learn how 30+ nations are protecting kids from AI risks like harmful content.
·
·
4 min read
The EU's 2027 drug pricing rules aim for transparency. See how this affects medicine costs, R&D disclosure, and global healthcare access.
·
·
9 min read
